21823 30TH DRIVE SE, BOTHELL, WA
News, Articles of Incorporation, Bylaws
Other Events
Third Quarter 2023 Financial Results Reflect Strong Product Sales Growth, and Significant Portfolio and Pipeline Progress
Other Events, Press Release
Seagen's Phase 3 TUKYSA Trial Meets Primary Endpoint in HER2-Positive Breast Cancer
Second Quarter 2023 Financial Results Demonstrate Exceptional Commercial Performance Driving Record Product Sales with Strong Growth and Momentum
Q3
Q2
Q1
FY 2022
FY 2021
Notice of Suspension of Duty to File Reports
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Merger Proxy Statement
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
S-8 POS